IRMD
IRadimed Corporation (IRMD) PESTLE Analysis Analysis (2026)
Political
No material political developments were reported this month for IRMD.
Economic
IRMD continues to show strong profitability and liquidity, but valuation remains elevated with price-to-sales at 12.9x and price-to-earnings at 47.9x.
Social
No new social or demographic demand signals were reported this month.
Technological
IRMD maintains solid operating performance with gross margin at 75.9% and operating margin at 31.9%, supporting its technology-enabled product position.
Legal
No new litigation, regulatory, or compliance developments were reported this month.
Environmental
No material environmental developments were reported this month.
Overall Score
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on IRadimed Corporation. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.